Deadline for public consultation: 31 December 2011
Deadline for coming into operation: 6 months after publication

Download / Télécharger le fichier .pdf


 The wholesale distribution of medicinal products is an important activity in the integrated supply chain management. Today’s distribution network for medicinal products is increasingly complex and involves many players. The quality and the integrity of medicinal products can be affected by a lack of adequate control over the numerous activities, which occur during distribution and it is also necessary to address the threat that falsified medicinal products pose to the distribution channel. It is necessary to exercise control over the entire chain of distribution objectives by observing good manufacturing practice of medicinal products. This policy ensures that products manufactured in, or imported into the European Union are of the appropriate quality. This level of quality should be maintained throughout the distribution network without any alteration.